Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 8/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 7/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21574389 | 0.92 | SIGMAR1 (0.43) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL23956553 | 0.91 | SLC6A4 (0.39) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL27883571 | 0.90 | SIGMAR1 (0.36) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL14976680 | 0.87 | SIGMAR1 (0.37) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL4308594 | 0.86 | SIGMAR1 (0.45) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL25014145 | 0.85 | GNAI3 (0.34) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL369682 | 0.85 | GNAO1 (0.43) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL21581280 | 0.83 | GNAO1 (0.46) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL21581261 | 0.83 | GNAO1 (0.46) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 | |
| SCHEMBL22702328 | 0.83 | GNAO1 (0.42) | SLC6A4SLC6A2SLC6A3SIGMAR1GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196930-A2 | NICOTINAMIDE- AND BENZAMIDE-BASED COMPOUNDS, CONJUGATES, AND COMPOSITIONS AS INHIBITORS OF TRANSLATIONAL- AND TRANSCRIPTIONAL-RELATED KINASES | PURDUE RESEARCH FOUNDATION (US) | 2023-10-12 | — | — | WO | disclosed |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-4194452-A1 | AROMATIC COMPOUND AND APPLICATION THEREOF IN ANTITUMOR DRUG | Shanghai Zheye Biotechnology Co., Ltd. (CN) | 2023-06-14 | — | — | EP | disclosed |
| US-11142629-B2 | Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-12 | — | — | US | disclosed |
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-09-10 | — | — | US | disclosed |
| US-20190300674-A1 | HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-10-03 | — | — | US | disclosed |
| WO-2016157074-A1 | 6-MORPHOLINYL-2-PYRAZOLYL-9H-PURINE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2016-10-06 | — | — | WO | disclosed |
| US-7524587-B2 | Non-aqueous electrolyte and secondary battery containing same | PANASONIC CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20070275305-A1 | Non-aqueous electrolyte and secondary battery containing same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2007-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200283567-A1 | COMPOUND, EPOXY CURING CATALYST AND METHOD FOR PRODUCING COMPOUND | MSMO1, RIOK1, ME1 | SLC6A4 4776/4885SLC6A2 4686/4885SLC6A3 4849/4885 |
| US-11718587-B2 | Compound, epoxy curing catalyst and method for producing compound | MSMO1, RIOK1, ME1 | SLC6A4 4776/4885SLC6A2 4686/4885SLC6A3 4849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.